Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 718946, 7 pages
http://dx.doi.org/10.1155/2014/718946
Research Article

Serum IL-17, IL-23, and TGF-β Levels in Type 1 and Type 2 Diabetic Patients and Age-Matched Healthy Controls

1Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran 1417755469, Iran
2Endocrinology and Metabolism Research Center (EMRC), Dr. Shariati Hospital, Tehran University of Medical Sciences, Tehran 1411413137, Iran
3Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran 1417613151, Iran
4Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran 1417613151, Iran
5Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran 1417613151, Iran
6Department of Public Health, Alborz University of Medical Sciences, Karaj 3139614171, Iran
7Department of Epidemiology, Iran University of Medical Sciences, Tehran 1449614535, Iran
8Department of Community and Preventive Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran 1417613151, Iran
9Department of Immunology, School of Medicine, Mazandaran University of Medical Sciences, Sari 4817844718, Iran
10Department of Pathology, Children’s Medical Center Hospital, Tehran University of Medical Sciences, Tehran 1419733151, Iran
11Farmanfarmaian Health Center, Tehran University of Medical Sciences, Tehran 1318618311, Iran

Received 6 February 2014; Revised 14 May 2014; Accepted 14 May 2014; Published 4 June 2014

Academic Editor: Robin Vos

Copyright © 2014 Azam Roohi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. DIAMOND Project Group, “Incidence and trends of childhood Type 1 diabetes worldwide 1990–1999,” Diabetic Medicine, vol. 23, no. 8, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. K. G. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Google Scholar
  3. P. A. Rowe, M. L. Campbell-Thompson, D. A. Schatz, and M. A. Atkinson, “The pancreas in human type 1 diabetes,” Seminars in Immunopathology, vol. 33, no. 1, pp. 29–43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Willcox, S. J. Richardson, A. J. Bone, A. K. Foulis, and N. G. Morgan, “Analysis of islet inflammation in human type 1 diabetes,” Clinical and Experimental Immunology, vol. 155, no. 2, pp. 173–181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Lechleitner, T. Koch, M. Herold, A. Dzien, and F. Hoppichler, “Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors,” Journal of Internal Medicine, vol. 248, no. 1, pp. 67–76, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. H. P. Chase, S. Cooper, I. Osberg et al., “Elevated C-reactive protein levels in the development of type 1 diabetes,” Diabetes, vol. 53, no. 10, pp. 2569–2573, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Dogan, S. Akarsu, B. Ustundag, E. Yilmaz, and M. K. Gurgoze, “Serum IL-1β, IL-2, and IL-6 in insulin-dependent diabetic children,” Mediators of Inflammation, vol. 2006, Article ID 59206, 6 pages, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Fève and J. P. Bastard, “The role of interleukins in insulin resistance and type 2 diabetes mellitus,” Nature Reviews Endocrinology, vol. 5, no. 6, pp. 305–311, 2009. View at Publisher · View at Google Scholar
  9. E. Rouvier, M.-F. Luciani, M.-G. Mattei, F. Denizot, and P. Golstein, “CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus Saimiri gene,” Journal of Immunology, vol. 150, no. 12, pp. 5445–5456, 1993. View at Google Scholar · View at Scopus
  10. L. E. Harrington, R. D. Hatton, P. R. Mangan et al., “Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages,” Nature Immunology, vol. 6, no. 11, pp. 1123–1132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. S. Maddur, P. Miossec, S. V. Kaveri, and J. Bayry, “Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies,” The American Journal of Pathology, vol. 181, no. 1, pp. 8–18, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. K. Marwaha, S. Q. Crome, C. Panagiotopoulos et al., “Cutting edge: increased IL-17-secreting T cells in children with new-onset type 1 diabetes,” Journal of Immunology, vol. 185, no. 7, pp. 3814–3818, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. Emamaullee, J. Davis, S. Merani et al., “Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice,” Diabetes, vol. 58, no. 6, pp. 1302–1311, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Derynck and K. Miyazono, “TGF-beta and the TGF-beta family,” in The TGF-Beta Family, R. Derynck and K. Miyazono, Eds., pp. 29–43, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA, 2008. View at Google Scholar
  15. G. J. Prud'homme, “Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations,” Laboratory Investigation, vol. 87, no. 11, pp. 1077–1091, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. O. Li, Y. Y. Wan, S. Sanjabi, A.-K. L. Robertson, and R. A. Flavell, “Transforming growth factor-β regulation of immune responses,” Annual Review of Immunology, vol. 24, pp. 99–146, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger, “TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells,” Immunity, vol. 24, no. 2, pp. 179–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. P. R. Mangan, L. E. Harrington, D. B. O'Quinn et al., “Transforming growth factor-β induces development of the T H17 lineage,” Nature, vol. 441, no. 7090, pp. 231–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Das, G. Ren, L. Zhang et al., “Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation,” The Journal of Experimental Medicine, vol. 206, no. 11, pp. 2407–2416, 2009. View at Publisher · View at Google Scholar
  21. K. Boniface, B. Blom, Y.-J. Liu, and R. de Waal Malefyt, “From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited,” Immunological Reviews, vol. 226, no. 1, pp. 132–146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Olivieri, S. de Angelis, S. Dionisi et al., “Serum transforming growth factor β1 during diabetes development in non-obese diabetic mice and humans,” Clinical and Experimental Immunology, vol. 162, no. 3, pp. 407–414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Zhi, A. Sharma, S. Purohit et al., “Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassays,” Molecular & Cellular Proteomics, vol. 10, no. 11, Article ID M111.012203, 2011. View at Google Scholar · View at Scopus
  24. D. Han, C. A. Leyva, D. Matheson et al., “Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes,” Clinical Immunology, vol. 139, no. 3, pp. 290–301, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. S. T. Azar, I. Salti, M. S. Zantout, and S. Major, “Alterations in plasma transforming growth factor β in normoalbuminuric type 1 and type 2 diabetic patients,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 12, pp. 4680–4682, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Abbasi, P. Amiri, F. A. Sayahpour et al., “TGF-β and IL-23 gene expression in unstimulated PBMCs of patients with diabetes,” Endocrine, vol. 41, no. 3, pp. 430–434, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. G. H. Tesch, “Role of macrophages in complications of Type 2 diabetes,” Clinical and Experimental Pharmacology and Physiology, vol. 34, no. 10, pp. 1016–1019, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. R. Jung, Y. L. Min, P. Y. Seung, and J. H. Ho, “High glucose regulates cyclin D1/E of human mesenchymal stem cells through TGF-β1 expression via Ca2+/PKC/MAPKs and PI3K/Akt/mTOR signal pathways,” Journal of Cellular Physiology, vol. 224, no. 1, pp. 59–70, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Isono, M. C. Iglesias-de la Cruz, S. Chen, S. W. Hong, and F. N. Ziyadeh, “Extracellular signal-regulated kinase mediates stimulation of TGF-β1 and matrix by high glucose in mesangial cells,” Journal of the American Society of Nephrology, vol. 11, no. 12, pp. 2222–2230, 2000. View at Google Scholar · View at Scopus
  30. Y. Y. Wan and R. A. Flavell, “The roles for cytokines in the generation and maintenance of regulatory T cells,” Immunological Reviews, vol. 212, pp. 114–130, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. S. You, N. Thieblemont, M.-A. Alyanakian, J.-F. Bach, and L. Chatenoud, “Transforming growth factor-β and T-cell-mediated immunoregulation in the control of autoimmune diabetes,” Immunological Reviews, vol. 212, pp. 185–202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Franceschi, M. Bonafè, S. Valensin et al., “Inflamm-aging. An evolutionary perspective on immunosenescence,” Annals of the New York Academy of Sciences, vol. 908, pp. 244–254, 2000. View at Google Scholar · View at Scopus
  33. T. Singh and A. B. Newman, “Inflammatory markers in population studies of aging,” Ageing Research Reviews, vol. 10, no. 3, pp. 319–329, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. D. McFarlane, R. F. Wolf, K. A. McDaniel, and G. L. White, “Age-associated alteration in innate immune response in captive baboons,” Journals of Gerontology A: Biological Sciences and Medical Sciences, vol. 66, no. 12, pp. 1309–1317, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. E. L. Willis, R. F. Wolf, G. L. White, and D. McFarlane, “Age- and gender-associated changes in the concentrations of serum TGF-1β, DHEA-S and IGF-1 in healthy captive baboons (Papio hamadryas anubis),” General and Comparative Endocrinology, vol. 195, pp. 21–27, 2014. View at Publisher · View at Google Scholar
  36. Y. Lin, K. Nakachi, Y. Ito et al., “Variations in serum transforming growth factor-β1 levels with gender, age and lifestyle factors of healthy Japanese adults,” Disease Markers, vol. 27, no. 1, pp. 23–28, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Okamoto, Y. Gotoh, O. Uemura, S. Tanaka, T. Ando, and M. Nishida, “Age-dependent decrease in serum transforming growth factor (TGF)-beta 1 in healthy Japanese individuals; Population study of serum TGF-beta 1 level in Japanese,” Disease Markers, vol. 21, no. 2, pp. 71–74, 2005. View at Google Scholar · View at Scopus
  38. D. J. Grainger, D. E. Mosedale, and J. C. Metcalfe, “TGF-β in blood: a complex problem,” Cytokine and Growth Factor Reviews, vol. 11, no. 1-2, pp. 133–145, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Saurwein-Teissl, I. Blasko, K. Zisterer, B. Neuman, B. Lang, and B. Grubeck-Loebenstein, “An imbalance between pro- and anti-inflammatory cytokines, a characteristic feature of old age,” Cytokine, vol. 12, no. 7, pp. 1160–1161, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Bending, H. de la Peña, M. Veldhoen et al., “Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice,” Journal of Clinical Investigation, vol. 119, no. 3, pp. 565–572, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. N. Martin-Orozco, Y. Chung, S. H. Chang, Y.-H. Wang, and C. Dong, “Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells,” European Journal of Immunology, vol. 39, no. 1, pp. 216–224, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Shao, F. He, Y. Yang, G. Yuan, M. Zhang, and X. Yu, “Th17 cells in type 1 diabetes,” Cellular Immunology, vol. 280, no. 1, pp. 16–21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. C. L. Langrish, Y. Chen, W. M. Blumenschein et al., “IL-23 drives a pathogenic T cell population that induces autoimmune inflammation,” Journal of Experimental Medicine, vol. 201, no. 2, pp. 233–240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. A. M. C. Mus, F. Cornelissen, P. S. Asmawidjaja et al., “Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of Interleukin-22, but not Interleukin-21, in autoimmune experimental arthritis,” Arthritis and Rheumatism, vol. 62, no. 4, pp. 1043–1050, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. E. P. K. Mensah-Brown, A. Shahin, M. Al-Shamsi, and M. L. Lukic, “New members of the interleukin-12 family of cytokines: IL-23 and IL-27 modulate autoimmune diabetes,” Annals of the New York Academy of Sciences, vol. 1079, pp. 157–160, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. I. J. Goldberg, “Clinical review 124: diabetic dyslipidemia—causes and consequences,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 3, pp. 965–971, 2001. View at Publisher · View at Google Scholar · View at Scopus